Home/Pipeline/RareVision

RareVision

Rare Genetic Diseases

CommercialActive

Key Facts

Indication

Rare Genetic Diseases

Phase

Commercial

Status

Active

Company

Inocras

About Inocras

Inocras is a commercial-stage diagnostics and services company leveraging whole genome sequencing (WGS) and advanced bioinformatics to provide actionable insights in oncology and rare disease. Its core offerings include CancerVision for solid tumors, MRDVision for minimal residual disease detection, and RareVision for rare genetic disorders, all delivered through a CAP/CLIA lab with a two-week turnaround. The company serves patients, healthcare providers, and researchers, positioning itself at the intersection of clinical diagnostics and genomic research services.

View full company profile

Therapeutic Areas

Oncology Rare Diseases

Other Rare Genetic Diseases Drugs

Drug	Company	Phase	Status
Platform Development	Aurora Therapeutics	Pre-clinical	Active
Kidney Organoid Development	Rosebud Biosciences	Research	In Progress